This site is intended for healthcare professionals practicing in the US.
©2022 AstraZeneca. All rights reserved.
US-69609
Last Updated 11/22
Eosinophilic Granulomatosis with Polyangiitis (EGPA)
Connect with Us
Are you interested in learning more about the unmet need in EGPA care for patients? Would you like to meet with someone from the AstraZeneca Medical team to learn more about AstraZeneca’s ambition in transforming care in EGPA? Use the link below to connect with a Medical Science Liaison in your region. You can also connect with us at one of the following upcoming congresses.
Meet Us at a Congress
Western Society of Allergy, Asthma & Immunology (WSAAI)
Kamuela, Hawaii
February 4-8, 2024
American Academy of Allergy, Asthma & Immunology (AAAAI)
Washington, DC
February 23-26, 2024
Congress of Clinical Rheumatology (CCR) East
Destin, Florida
May 9-12, 2024
American Thoracic Society (ATS)
San Diego, California
May 17-22, 2024
Eastern Allergy Conference (EAC)
Palm Beach, Florida
May 30-June 2, 2024
European Alliance of Associations for Rheumatology (EULAR)
Vienna, Austria
June 12-15, 2024
European Academy of Allergy and Clinical Immunology (EAACI)
Valencia, Spain
May 31-June 3, 2024
Eastern Pulmonary Conference (EPC)
Palm Beach, Florida
September 12-15, 2024
Congress of Clinical Rheumatology (CCR) West
San Diego, California
September 26-29, 2024
European Respiratory Society (ERS)
Vienna, Austria
September 7-11, 2024
CHEST
Boston, Massachusetts
October 6-9, 2024
American College of Rheumatology (ACR)
Washington, DC
November 14-19, 2024
American College of Allergy, Asthma & Immunology (ACAAI)
Boston, Massachusetts
October 24-28, 2024
US-88106, US-91275 Last Updated 7/24
The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries.
This web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about AstraZeneca drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.
Are you a healthcare professional practicing in the United States?